Can AEHR's Diversification Strengthen Its Growth Outlook?

Zacks
Open on Zacks
Can AEHR's Diversification Strengthen Its Growth Outlook?

Aehr Test Systems, Inc. AEHR is building a broader growth story as demand expands beyond its traditional silicon carbide (SiC) exposure. Two years ago, more than 95% of its business was tied to SiC for electric vehicles (EVs). In fiscal 2026, nearly 95% of revenues came from markets outside EV-related SiC, signaling a major shift in its business mix.

AI has emerged as the biggest new contributor. AI accelerators, CPUs and network processors accounted for about 71% of fiscal 2026 revenues, while optical device test and burn-in for data-center infrastructure transceivers, chip-to-chip I/O and hard disk drives represented another 20%. The momentum has continued into fiscal 2027, with AEHR securing a $22 million follow-on order for AI processor wafer-level burn-in (WLBI) systems in August. Silicon photonics has also gained traction, with another follow-on production order received in August.

Power semiconductors provide another leg to the growth story. AEHR received roughly $8 million of new SiC WLBI orders in July as EV programs picked up. The company is also expanding into gallium nitride applications, while memory remains a longer-term opportunity spanning NAND and high-bandwidth memory (HBM).

This wider exposure could make AEHR less dependent on a single end market and help smooth its growth profile over time. The company’s $100.6 million effective backlog and $130-$150 million fiscal 2027 revenue outlook provide support for near-term growth. Still, sustaining that pace will depend on continued ramps in AI and silicon photonics, a recovery in power semiconductor demand and successful expansion into new applications.

AEHR Faces Stiff Competition

Aehr operates in a highly competitive semiconductor test equipment market, contending with strong rivals such as Teradyne, Inc. TER and FormFactor, Inc. FORM.

Teradyne is benefiting from the AI-led expansion in semiconductor testing, with its Semiconductor Test business gaining from rising demand for advanced compute and memory chips. HBM, DRAM and NAND testing are emerging as key growth drivers, strengthening TER’s position in the expanding AI test market.

FormFactor is benefiting from rising testing requirements for AI and HBM, particularly through its probe card business. Strong demand for DRAM and Foundry & Logic applications is supporting growth as AI workloads drive greater complexity and testing intensity across advanced semiconductors.

AEHR’s Share Price Performance, Valuation & Estimates

AEHR’s shares have surged 152.6% over the past six months, outperforming the broader industry’s 17.3% growth.

Zacks Investment Research
Image Source: Zacks Investment Research

Aehr shares are trading at a premium. On a forward 12-month price-to-sales (P/S) basis, AEHR trades at 19.05X, higher than the industry’s 5.72X.

Zacks Investment Research
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for AEHR’s fiscal 2027 earnings is pegged at 74 cents per share, a sharp increase from 3 cents a year ago.

Zacks Investment Research
Image Source: Zacks Investment Research

Aehr currently carries a Zacks Rank#2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Aehr Test Systems (AEHR): Free Stock Analysis Report
 
FormFactor, Inc. (FORM): Free Stock Analysis Report
 
Teradyne, Inc. (TER): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research